- Home
- CBU vs CNTA Comparison
CBU vs CNTA Comparison
Compare CBU & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBU | CNTA |
|---|---|---|
| Founded | 1866 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 6.1B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CBU | CNTA |
|---|---|---|
| Price | $63.04 | $39.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $66.67 | $43.17 |
| AVG Volume (30 Days) | 168.2K | ★ 3.0M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | 15.41 | ★ 29.13 |
| EPS | ★ 3.97 | N/A |
| Revenue | ★ $818,007,000.00 | $15,000,000.00 |
| Revenue This Year | $13.46 | N/A |
| Revenue Next Year | $7.75 | N/A |
| P/E Ratio | $15.68 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $51.12 | $10.95 |
| 52 Week High | $67.50 | $40.26 |
Technical Indicators
Market Signals| Indicator | CBU | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 73.08 |
| Support Level | $60.17 | $39.16 |
| Resistance Level | $64.73 | $40.26 |
| Average True Range (ATR) | 1.29 | 0.19 |
| MACD | 0.01 | -0.48 |
| Stochastic Oscillator | 65.93 | 58.16 |
Price Performance
Historical ComparisonAbout CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.